Navigation Links
Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
Date:8/8/2012

CHAPEL HILL, N.C., Aug. 8, 2012 /PRNewswire/ --  Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the second quarter ended June 30, 2012. The company will host a conference call and webcast at 4:30 p.m. EDT, today.

"We continued to make progress in our clinical programs during the second quarter," said Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra.  "We received comments on our proposed clinical design of the oral Phase 3 trial of solithromycin for community-acquired bacterial pneumonia from the Food and Drug Administration (FDA) and we plan to initiate our Phase 3 CABP oral study in 2012.  Based on their comments, we expect the trial to start in the fourth quarter of 2012. We had initiated our Phase 2 trial of solithromycin for the treatment of gonococcal infections in early June and we plan to report on the results of this study in the fourth quarter of 2012.  Finally, we plan to initiate the prosthetic joint infection Phase 2 trial in 2012 in which oral Taksta will be used for chronic administration."

Financial ResultsQuarter ended June 30, 2012 compared to quarter ended June 30, 2011For the quarter ended June 30, 2012, Cempra reported a net loss of $9.5 million, or $0.45 per share, compared to a net loss of $6.1 million, or $11.65 per share, for the comparable period in the quarter ended June 30, 2011. 

Research and development expense was $7.4 million, an increase of 70% compared to the quarter ended June 30, 2011. The higher R&D expense was due to increased clinical activities related to solithromycin as well as milestone and licensing payments under our licensing agreements related to solithromycin. General & Administrative ex
'/>"/>

SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
2. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
3. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
4. Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012
5. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
6. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
7. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
8. diaDexus, Inc. Reports Second Quarter 2012 Financial Results
9. HeartWare Reports Second Quarter 2012 Results
10. Omeros Corporation Reports Second Quarter 2012 Financial Results
11. Express Scripts Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... N.C. , July 11, 2014 ... pharmaceutical marketing and, consequently, organizations are turning to ... patients. As part of this evolving ... important to educate, communicate and engage patients throughout ... awareness to patient empowerment. By mapping the patient ...
(Date:7/11/2014)... Research and Markets  has announced the ... report to their offering. ... a hollow needle commonly used with a syringe to ... fluids from it. A hypodermic needle is used for ... cannot be ingested. Hypodermic needles are broadly classified into ...
(Date:7/11/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ) has ... Testing Market - Forecasts to 2019: Expected to ... is expected to be valued at USD 4,943.0 ... http://photos.prnewswire.com/prnh/20130307/600769 The ... according to immunoprotein types which include immunoglobulins, complement ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
(Date:7/13/2014)... New York, New York (PRWEB) July 13, 2014 ... much to bring attention to the cancer risks associated ... a chance to tell their story to federal regulators, ... of a U.S. Food & Drug Administration (FDA) ... Liebhard LLP reports. According to the Rochester Democrat ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July ... sensor for people with diabetes is being developed to measure ... researchers report. Scientists at Brown University in Providence, R.I., ... It uses light, metal and a special enzyme that changes ... diabetics have to prick their fingers to draw blood to ...
(Date:7/13/2014)... Houston, TX (PRWEB) July 13, 2014 The ... for children ranging in age from four months to 12 ... skills and karate classes to birthday parties and Summer Camps, ... the Little Gym of Pearland after spending over ... variety of roles, including Gym Director. , Berry has ...
(Date:7/13/2014)... July 13, 2014 Athletes with a ... period from concussions, according to research presented today at ... ) Annual Meeting. The research marks the first of ... on the known physical events that occur after a ... a long allele in the (GT)n genotype were four ...
(Date:7/13/2014)... New York, New York (PRWEB) July 13, 2014 ... mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against ... the litigation’s second bellwether trial, which is expected to ... Control Order issued in the U.S. District Court, Southern ... Pretrial Conference will be held on August 7, 2014 ...
Breaking Medicine News(10 mins):Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4
Fatehpur Sikri, Mughal Emperor Akbar's dream city, has come up some new finds, thanks to the labourious// excavatory work of the Archaeological Survey of India (ASI). ,According to Munazar Ali, a mo...
... from the University of Lund in Sweden have conducted ... of type 2 diabetes // . ,Exposure ... asthma, diabetes and many cancers. ,High levels of ... dichloro-diphenyl-trichloro-ethane or DDT in the blood of diabetic patients ...
... practices, massive migration and low awareness there has been ... disease // amongst the tribal community, living close to ... Ganjam, Kendrapara, Balasore Nuapada, Koraput, Rayagada, Phulbani and Sundargarh ... a challenge to the Government of Orissa. The percentage ...
... that loud noise can increase the risk of heart attacks ... to the noise related to the workplace as well as ... found that this noise had a physiological effect on the ... Medicine, Epidemiology and Health Economics at Charite University Medical Centre ...
... to have succumbed to pneumonia in the earthquake affected ... The severe cold in the earthquake-hit areas is reported ... hundred people. The inadequate medical facilities in the quake-hit ... pneumonia. ,'More than 30 people have been reported ...
... Beer as it is, is a very popular drink in Europe ... there have manufactured a healthy beer called karla //, which they ... cancer. ,The beer is made form herbs and also ... also with a lower alcohol percentage. Chemists claim that the sale ...
Cached Medicine News:Health News:High Decibel Levels Raise Heart Disease Risk 2Health News:Pneumonia Claims 30 Lives In Pakistan 2
One channel transcranial Doppler...
Locates flow easily, and identifies flow depth and direction for multiple vessels simultaneously....
... an advanced Doppler system that allows non-invasive ... body. This method of measurement is particularly ... blood to the brain. , ,TCD is ... problems such as vasospasm and intracranial stenosis. ...
Swiss Watchmaker Forceps, 4" extra-long precision ground points....
Medicine Products: